ZIMMER BIOMET HOLDINGS, INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $3.20 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2018-02-27
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $3.20M, a 58.97% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $1.50M, a 7.14% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-09-30 was $1.20M, a 9.09% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-06-30 was $1.30M, a 59.38% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $11.80M, a 6.31% increase from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $11.10M, a 29.07% increase from fiscal 2013.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $8.60M, a 218.52% increase from fiscal 2012.
- ZIMMER BIOMET HOLDINGS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2012 was $2.70M, a 46.00% decline from fiscal 2011.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2016-03-31 | $3.20M 10-Q · filed 2016-05-10 | $4.70M derived: sum of 2 quarters · filed 2018-02-27 | $5.90M derived: sum of 3 quarters · filed 2018-02-27 | $7.20M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.70M derived: sum of 2 quarters · filed 2018-02-27 | $4.00M derived: sum of 3 quarters · filed 2018-02-27 | $11.80M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $2.50M derived: sum of 2 quarters · filed 2016-11-08 | $10.30M 10-Q · filed 2016-11-08 | $11.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $9.10M 10-Q · filed 2016-08-08 | $10.50M derived: sum of 3 quarters · filed 2017-03-01 | $11.60M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $7.80M 10-Q · filed 2016-05-10 | $9.20M derived: sum of 2 quarters · filed 2017-03-01 | $10.30M derived: sum of 3 quarters · filed 2017-03-01 | $13.50M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.50M derived: sum of 2 quarters · filed 2017-03-01 | $5.70M derived: sum of 3 quarters · filed 2017-03-01 | $11.10M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.30M derived: sum of 2 quarters · filed 2015-11-09 | $9.70M 10-Q · filed 2015-11-09 | $11.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $8.60M 10-Q · filed 2015-08-10 | $9.90M derived: sum of 3 quarters · filed 2016-02-29 | $12.10M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $5.40M 10-Q · filed 2015-05-07 | $6.70M derived: sum of 2 quarters · filed 2016-02-29 | $8.90M derived: sum of 3 quarters · filed 2016-02-29 | $10.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.50M derived: sum of 2 quarters · filed 2016-02-29 | $5.10M derived: sum of 3 quarters · filed 2016-02-29 | $8.60M 10-K · filed 2016-02-29 |
| 2013-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $3.80M derived: sum of 2 quarters · filed 2014-11-05 | $7.30M 10-Q · filed 2014-11-05 | $7.70M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.10M 10-Q · filed 2014-08-07 | $5.50M derived: sum of 3 quarters · filed 2015-02-23 | $6.40M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $3.50M 10-Q · filed 2014-05-06 | $3.90M derived: sum of 2 quarters · filed 2015-02-23 | $4.80M derived: sum of 3 quarters · filed 2015-02-23 | $5.00M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $1.30M derived: sum of 2 quarters · filed 2015-02-23 | $1.50M derived: sum of 3 quarters · filed 2015-02-23 | $2.70M 10-K · filed 2015-02-23 |
| 2012-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.10M derived: sum of 2 quarters · filed 2013-11-12 | $2.30M 10-Q · filed 2013-11-12 | $3.30M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.40M 10-Q · filed 2013-08-07 | $2.40M derived: sum of 3 quarters · filed 2014-02-28 | $2.80M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $1.20M 10-Q · filed 2013-05-08 | $2.20M derived: sum of 2 quarters · filed 2014-02-28 | $2.60M derived: sum of 3 quarters · filed 2014-02-28 | $3.80M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.40M derived: sum of 2 quarters · filed 2014-02-28 | $2.60M derived: sum of 3 quarters · filed 2014-02-28 | $5.00M 10-K · filed 2014-02-28 |
| 2011-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.60M derived: sum of 2 quarters · filed 2012-11-06 | $4.00M 10-Q · filed 2012-11-06 | $4.20M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $3.60M 10-Q · filed 2012-08-07 | $3.80M derived: sum of 3 quarters · filed 2013-02-27 | $3.90M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $2.40M 10-Q · filed 2012-05-03 | $2.60M derived: sum of 2 quarters · filed 2013-02-27 | $2.70M derived: sum of 3 quarters · filed 2013-02-27 | $3.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $300.00K derived: sum of 2 quarters · filed 2013-02-27 | $600.00K derived: sum of 3 quarters · filed 2013-02-27 | $1.30M 10-K · filed 2013-02-27 |
| 2010-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $400.00K derived: sum of 2 quarters · filed 2011-11-02 | $1.10M 10-Q · filed 2011-11-02 | $1.40M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $1.00M 10-Q · filed 2011-08-08 | $1.30M derived: sum of 3 quarters · filed 2012-02-27 | $1.40M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $700.00K 10-Q · filed 2011-05-05 | $1.00M derived: sum of 2 quarters · filed 2012-02-27 | $1.10M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $400.00K derived: sum of 2 quarters · filed 2012-02-27 | $400.00K 10-K · filed 2012-02-27 | |
| 2009-09-30 | $100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $100.00K 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | $0.00 10-Q/A · filed 2009-08-17 | |||
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $500.00K derived: sum of 2 quarters · filed 2011-02-25 | $6.50M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $500.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-04 | $6.50M 10-Q · filed 2009-11-04 | ||
| 2008-06-30 | $6.00M 10-Q/A · filed 2009-08-17 | |||
| 2007-12-31 | $27.00M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |